Lightstone Ventures β 2019 Investments
4 investments dated 2019 Β· listed companies and verified rows first Β· show all
Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization.
HardwareHealthtechMedical DevicesRaleigh, US
Ravish Sachar(CEO & Founder)Paul Sanders(Chief Operating Officer)
Board seatHanson S. GiffordΒ· per SEC Form D
Co-investorsHatteras Venture PartnersAmzak HealthMountain Group CapitalUS Venture Partners
Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease.
HealthtechMedical DevicesWayne, US
Bruce J. Shook(President and CEO)Monica Klos(Executive Officer)Neil Hattangadi(Director)Peter Schneider(Director)Mark Garcia(Director)Dennis W. Wahr(Director)
Co-investorsNew Enterprise Associates (NEA)Gilde HealthcareVensana Capital415 Capital
Allay Therapeutics develops localized pain management technology designed to deliver several weeks of post-surgical pain relief.
BiotechHealthtechMedical DevicesSan Jose, US
Adam Gridley(Executive Officer, Director)Kristen Howells(Executive Officer)Josh Makower(Director)Tak Cheung(Director)Karun D. Naga(Executive Officer, Director)
BoardLeighton Read(Director)
Board seatMichael A. CarusiHanson S. GiffordΒ· per SEC Form D
Co-investorsArboretum VenturesNew Enterprise Associates (NEA)SGInnovateClavystBio
Singapore-based immune engineering company developing novel cellular therapies for T-cell malignancies and autoimmune diseases.
Singapore
Board seatMichael A. CarusiΒ· per SEC Form D
Co-investorsClavystBioOUP (Osage University Partners)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.